Abstract

BackgroundClinical research indicates that periconceptional administration of folic acid can reduce the occurrence of congenital cardiac septal defects (CCSDs). The vital roles of folate exhibits in three ways: the unique methyl donor for DNA expression regulation, the de novo biosynthesis of purine and pyrimidine for DNA construction, and the serum homocysteine removal. Thymidylate synthase (TYMS) is the solo catalysis enzyme for the de novo synthesis of dTMP, which is the essential precursor of DNA biosynthesis and repair process. To examine the role of TYMS in Congenital Cardiac Septal Defects (CCSDs) risk, we investigated whether genetic polymorphisms in the TYMS gene associated with the CCSDs in a Han Chinese population.MethodPolymorphisms in the noncoding region of TYMS were identified via direct sequencing in 32 unrelated individuals composed of half CCSDs and half control subjects. Nine SNPs and two insertion/deletion polymorphisms were genotyped from two independent case-control studies involving a total of 529 CCSDs patients and 876 healthy control participants. The associations were examined by both single polymorphism and haplotype tests using logistic regression.ResultWe found that TYMS polymorphisms were not related to the altered CCSDs risk, and even to the changed risk of VSDs subgroup, when tested in both studied groups separately or in combination. In the haplotype analysis, there were no haplotypes significantly associated with risks for CCSDs either.ConclusionOur results show no association between common genetic polymorphisms of the regulatory region of the TYMS gene and CCSDs in the Han Chinese population.

Highlights

  • Congenital heart disease is one of the most common birth defects and among the leading causes of infant death worldwide, with an incidence of 19 to 75 per 1,000 live births [1]

  • Result: We found that Thymidylate synthase (TYMS) polymorphisms were not related to the altered cardiac septal defects (CCSDs) risk, and even to the changed risk of ventricular septal defects (VSDs) subgroup, when tested in both studied groups separately or in combination

  • Our results show no association between common genetic polymorphisms of the regulatory region of the TYMS gene and CCSDs in the Han Chinese population

Read more

Summary

Introduction

Congenital heart disease is one of the most common birth defects and among the leading causes of infant death worldwide, with an incidence of 19 to 75 per 1,000 live births [1]. Clinical research over the past twenty years suggests that maternal periconceptional folic acid supplementation would reduce the occurrence of congenital heart disease by 40–60%, especially for congenital cardiac septal defects (CCSDs) and conotruncal defects [2,3,4,5,6,7,8,9]. Folate acts as a one-carbon donor, which is involved in both the de novo synthesis of nucleotides and methyl transfer reactions. Clinical research indicates that periconceptional administration of folic acid can reduce the occurrence of congenital cardiac septal defects (CCSDs). To examine the role of TYMS in Congenital Cardiac Septal Defects (CCSDs) risk, we investigated whether genetic polymorphisms in the TYMS gene associated with the CCSDs in a Han Chinese population

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call